Groundbreaking Malaria Vaccine under Test
Why in news?
- The World Health Organisation welcomed a pilot project in Malawi of administering a malaria vaccine to children below the age of 2 years. A total 3,60,000 children across three African countries — Malawi, Ghana and Kenya — will be covered every year with the vaccine.
What is the RTS, S (Mosquirix) vaccine?
- RTS, S/AS01 (trade name Mosquirix) is a recombinant protein-based malaria vaccine.
- A pilot project for vaccination has been launched on April 23, 2019 in Malawi. Ghana and Kenya are to join the program later this year.
- The vaccine has been developed by GSK (GlaxoSmithKline ) ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 Gender Neutrality in Indian Laws: An Unfinished Agenda
- 2 Global Pandemic Treaty: A Milestone in International Health Diplomacy
- 3 Caste Census: Significance and Challenges
- 4 India-UK Free Trade Deal: Big Gains, Bigger Challenges
- 5 India’s Global Diplomatic Outreach
- 6 The Legal and Ethical Quandaries of Opinion Trading Platform
- 7 Harnessing Technology and Innovation in Indian Aquaculture
- 8 India’s Steady Economic Growth: Resilience in the Face of Global Headwinds
- 9 The Absence of Agriculture in India’s FTA: Causes and Implications
- 10 Indian’s Extended Continental Shelf Claim in Arabian Sea
